MPMonika Peckova

Monika Peckova

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Monika Peckova has a total of 26 co-authors. Here are the top co-authors by number of shared publications:

  • Al Hallstrom

    AVID Clinical Trial Center, Department of Biostatistics, University of Washington, 1107 NE 45th Street, Room 505, Seattle, WA 98105, U.S.A.

    1 shared publication
  • Alena Spirkova

    Department of Pediatrics, 2nd Faculty of Medicine, Charles University in Prague and University Hospital in Motol, V Uvalu 84, 15006 Prague, Czech Republic ; Department of Psychology, Faculty of Arts, Charles University in Prague, 11000 Prague, Czech Republic

    1 shared publication
  • Alfred P. Hallstrom

    1 shared publication
  • B Genicot

    Faculté de Médecine Vétérinaire, Université de Liège, Belgium

    1 shared publication
  • Barbora Obermannova

    Department of Pediatrics, 2nd Faculty of Medicine, Charles University in Prague and University Hospital in Motol, V Uvalu 84, 15006 Prague, Czech Republic

    1 shared publication
  • Carol E. Fahrenbruch

    1 shared publication

Latest Publications

  • Open Access

    Antibody response of definitive hosts against antigens of two life stages of the neuropathogenic schistosome Trichobilharzia regenti

    by Libuše Turjanicová, Libor Mikeš, Monika Pecková, Petr Horák

    The nasal avian schistosome Trichobilharzia regenti spends part of its intravertebrate period of life within the central nervous system. Migration of the parasites can be accompanied by neuromotor disorders or paralysis in natural definitive hosts (ducks) and even in laboratory mammals. Cercariae are also able to penetrate human skin and induce cercarial dermatitis. While the cellular and antibody responses against cercariae and migrating schistosomula have been investigated in mice, little is known about immune reactions in birds. This study first describes the dynamics of antibody response in infected ducks and identifies frequently recognized antigens that may serve as diagnostic markers of infection by T. regenti. Groups of 35 domestic ducks and 10 mallards were exposed to different doses of T. regenti cercariae. Sera were collected at predefined time intervals and tested by ELISA for the presence of specific anti-cercarial IgY and IgM. Antigens recognized by the antibodies were identified on Western blots of cercariae and schistosomula. The applicability in immunodiagnostics was statistically evaluated by expression of specificity and sensitivity values for individual antigens. In ELISA, the levels of anti-cercarial IgM peaked on day 15 pi. Increased production of IgY associated with the later phases of infection was observed in most individuals around 20 dpi and culminated 30 dpi. The time course of antibody response did not differ among experimental groups, variations were only observed in the levels of specific IgY which depended rather on the age of ducks at the time of infection than on the infectious dose. On Western blots, 40 cercarial and 7 schistosomular antigens were recognized by IgY from infected ducks. Among them, 4 cercarial antigens of 50, 47, 32 and 19 kDa provided the most sensitive and specific reactions. Antigens of cercariae and schistosomula elicited distinct antibody response in ducks, which correlated positively with the age of animals at the time of infection. Several antigens originating in cercariae and fewer in schistosomula were recognized by IgY with diverse sensitivity and specificity; only a few seemed to be common to both stages. Four of them were considered as the most promising candidates for immunodiagnostics.


  • Open Access

    Treated Autoimmune Thyroid Disease Is Associated with a Decreased Quality of Life among Young Persons with Type 1 Diabetes

    by Alena Spirkova, Petra Dusatkova, Monika Peckova, Stanislava Kolouskova, Marta Snajderova, Barbora Obermannova, Katerina Stechova, Tamara Hrachovinova, Jiri Mares, Ondrej Cinek, et al.

    Type 1 diabetes (T1D) in children and adolescents is relatively often accompanied by other immunopathological diseases, autoimmune thyroid disease (AITD) or celiac disease (CD). Our aim was to assess whether these conditions are associated with changes in the health-related quality of life (HRQOL) in pediatric patients with T1D. In a cross-sectional study we identified eligible 332 patients with T1D aged 8–18 years, of whom 248 (75%) together with their parents responded to the PedsQL Generic and Diabetes Modules. Compared to 143 patients without thyroid autoantibodies, 40 patients with a thyroxine-treated AITD scored lower in the overall generic HRQOL(P=0.014), as well as in the overall diabetes-specific HRQOL(P=0.013). After adjustment for age, gender, duration of diabetes, type of diabetes treatment, and diabetes control, this association remained statistically significant for the generic HRQOL(P=0.023). Celiac disease was not associated with a change in the generic or diabetes-specific HRQOL (P=0.07  and   P=0.63, resp.). Parental scores showed no association with AITD or celiac disease, except a marginally significant decrease in the overall generic HRQOL(P=0.039)in the T1D + AITD compared to T1D group. Our study indicates that, in pediatric patients with T1D, concomitant thyroxine-treated AITD is associated with lower quality of life.


  • Adaptive Test for Testing the Difference in Survival Distributions

    by Monika Pecková, Thomas R. Fleming

    An adaptive test is proposed for the problem of testing the difference in survival distributions when the shape of the hazard ratio is unknown, hence the efficient test is unknown. The proposed...


  • Weekly and seasonal variation in the incidence of cardiac arrests

    by Monika Peckova, Carol E. Fahrenbruch, Leonard A. Cobb, Alfred P. Hallstrom


  • A simulation study used to design the sequential monitoring plan for a clinical trial

    by Maria Mori Brooks, Al Hallstrom, Monika Peckova

    In designing a sequential monitoring plan for the AVID (Antiarrhythmics Versus Implantable Defibrillators) study, a multi‐centred clinical trial, we completed a simulation study to help ourselves and the Data Safety Monitoring Board understand the implications of various monitoring plans. In particular, we compared three test statistics and three use functions. Simulation was based on approximate trial parameters and two plausible but distinct alternative hypotheses. The power to detect a difference between the two treatment arms was computed as a function of time. The simulated results illuminate several of the important statistical and ethical issues involved in selecting a sequential monitoring plan and illustrate how one can use simulations to design a clinical trial.


    • 1 January 1994
      • Vol. 25  (5) , 468-77

    Technical study of some major parameters influencing the performance of an aerosol delivery equipment suitable for calves.

    by B Genicot, M Peckova, R Close, J K Lindsey, P Lambert, P Lekeux

    Aerosol delivery equipment, suitable for the treatment of bovine respiratory dysfunctions and including 2 parallelly positioned jet nebulizers, was studied in depth in order to determine the optimal working conditions in the field. Indeed, some factors might reasonably alter the performance of this equipment. Among these factors, the influences of the parallel position of jet nebulizers (in order to accommodate the breathing requirements of the cattle and achieve a rapid treatment), of the long feed pipe delivering compressed air (in order to keep the animal away from the compressor unit), and finally of the ambient temperature were studied, this equipment being essentially used during the winter season. This equipment could accommodate the breathing needs of cattle weighing up to 225 kg if a pressure of 600 kPa was developed upstream to the nebulizers. The rate of atomization was significantly reduced when working at ambient air temperatures (272.25 K < T < 274.65 K) close to those encountered in winter. This was especially true when pressure upstream to the nebulizers did not exceed 500 kPa. The immersion of the feed pipe for compressed air in hot water led to an increase in the rate of atomization without raising evaporative water losses, and reduced the drop in temperature in the nebulizer solution. Finally, the rate of atomization significantly increased when the face mask including the nebulizers was maintained so that the nebulizers were in a vertical position or at an angle not less than 60 degrees with respect to the ground.